Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor

Gobinda Sarkar(Mayo Clinic), Steve S. Sommer(City Of Hope National Medical Center), Leonard L. Heston, Janet L. Sobell(Mayo Clinic), Mark A. Marchionni, Olivier Civelli(University of California, Irvine), Stephen Kapelner(Mayo Clinic), David K. Grandy(Oregon Health & Science University)
Genomics
September 1, 1991
Cited by 113


Related Papers